Richard Walwema

Richard Walwema

Auto-generated profile, based on publicly available information

Richard Walwema

Global Health Security Program, Makerere University Infectious Diseases Institute, Kampala, Uganda

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2021 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
SNSusan Nabadda
Susan Nabadda
FKFrancis Kakooza
Francis Kakooza
RKReuben Kiggundu
Reuben Kiggundu
RWRichard Walwema
Richard Walwema
JBJoel Bazira
Joel Bazira
HMHenry Mwebasa
Henry Mwebasa
Background: Antimicrobial resistance (AMR) is an emerging public health crisis in Uganda. The World Health Organization (WHO) Global Action Plan recommends that countries should develop and implement National Action Plans for AMR. We describe the establishment of the national AMR program in Uganda and present the early microbial sensitivity results from the program. Objective: The aim of this study is to describe a national surveillance program that was developed to perform the systematic and continuous collection, analysis, and interpretation of AMR data. Methods: A systematic qualitative description of the process and progress made in the establishment of the national AMR program is provided, detailing the progress made from 2015 to 2020. This is followed by a report of the findings of the isolates that were collected from AMR surveillance sites. Identification and antimicrobial susceptibility testing (AST) of the bacterial isolates were performed using standard methods at both the surveillance sites and the reference laboratory. Results: Remarkable progress has been achieved in the establishment of the national AMR program, which is guided by the WHO Global Laboratory AMR Surveillance System (GLASS) in Uganda. A functional national coordinating center for AMR has been established with a supporting designated reference laboratory. WHONET software for AMR data management has been installed in the surveillance sites and laboratory staff trained on data quality assurance. Uganda has progressively submitted data to the WHO GLASS reporting system. Of the 19,216 isolates from WHO GLASS priority specimens collected from October 2015 to June 2020, 22.95% (n=4411) had community-acquired infections, 9.46% (n=1818) had hospital-acquired infections, and 68.57% (n=12,987) had infections of unknown origin. The highest proportion of the specimens was blood (12,398/19,216, 64.52%), followed by urine (5278/19,216, 27.47%) and stool (1266/19,216, 6.59%), whereas the lowest proportion was urogenital swabs (274/19,216, 1.4%). The mean age was 19.1 (SD 19.8 years), whereas the median age was 13 years (IQR 28). Approximately 49.13% (9440/19,216) of the participants were female and 50.51% (9706/19,216) were male. Participants with community-acquired infections were older (mean age 28, SD 18.6 years; median age 26, IQR 20.5 years) than those with hospital-acquired infections (mean age 17.3, SD 20.9 years; median age 8, IQR 26 years). All gram-negative (Escherichia coli, Klebsiella pneumoniae, and Neisseria gonorrhoeae) and gram-positive (Staphylococcus aureus and Enterococcus sp) bacteria with AST showed resistance to each of the tested antibiotics. Conclusions: Uganda is the first African country to implement a structured national AMR surveillance program in alignment with the WHO GLASS. The reported AST data indicate very high resistance to the recommended and prescribed antibiotics for treatment of infections. More effort is required regarding quality assurance of laboratory testing methodologies to ensure optimal adherence to WHO GLASS–recommended pathogen-antimicrobial combinations. The current AMR data will inform the development of treatment algorithms and clinical guidelines.

10 June 2020 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
MWMeklit Workneh
Meklit Workneh
MHMatthew M Hamill
Matthew M Hamill
FKFrancis Kakooza
Francis Kakooza
EMEmmanuel Mande
Emmanuel Mande
JWJessica Wagner
Jessica Wagner
YMYukari C Manabe
Yukari C Manabe
Background: Neisseria gonorrhoeae (commonly known as gonorrhea) has developed resistance to all first-line therapy in Southeast Asia. East Africa has historically had absent or rudimentary gonorrhea surveillance programs and, while the existence of antimicrobial-resistant gonorrhea is recognized, the extent of its resistance is largely unknown. In 2016, the World Health Organization’s Enhanced Gonococcal Antimicrobial Surveillance Program (EGASP) was initiated in Uganda to monitor resistance trends. Objective: This study characterizes gonorrhea and antibiotic resistance in a large surveillance program of men with urethral discharge syndrome from Kampala, Uganda. Methods: Men attending sentinel clinics with urethritis provided demographic information, behavior data, and a urethral swab in line with the World Health Organization’s EGASP protocols for culture, identification, and antibiotic-sensitivity testing using 2 methods—disk diffusion (Kirby-Bauer test) and Etest (BioMérieux Inc). A subset of samples underwent detailed antimicrobial resistance testing. Results: Of 639 samples collected from September 2016 to February 2018, 400 (62.6%) were culture-positive though 414 (64.8%) had microscopic evidence of gonorrhea. The mean age of the men from whom the samples were collected was 26.9 (SD 9.6) years and 7.2% (46/639) reported having HIV. There was high-level resistance to ciprofloxacin, tetracycline, and penicillin (greater than 90%) by Kirby-Bauer disk diffusion and 2.1% (4/188) had reduced azithromycin sensitivity by Etest. Of the early isolates that underwent detailed characterization, 60.3% (70/116) were culture-positive, 94% (66/69) isolates were either ciprofloxacin-resistant or ciprofloxacin-intermediate by Etest, 96% (65/68) were azithromycin-sensitive, and 96% (66/69) were gentamicin-sensitive. Resistance profiles were comparable between methods except for ceftriaxone (disk diffusion: 68/69, 99%; Etest: 67/69, 97%) and for gentamicin (disk diffusion: 2/8, 25%; Etest: 66/69, 96%) sensitivity. Conclusions: This is the first report from a systematic gonorrhea surveillance program in Uganda. Findings demonstrated resistance or increased minimum inhibitory concentration to all key antigonococcal antibiotics. There was evidence of poor antibiotic stewardship, near-universal resistance to several antibiotics, and emerging resistance to others. Individuals in the population sampled were at exceptionally high risk of STI and HIV infection requiring intervention. Ongoing surveillance efforts to develop interventions to curtail antimicrobial-resistant gonorrhea are needed.

7 May 2024 in JMIRx Bio
Verified
Journal Article
Open access
GKGodfrey Katumba
Godfrey Katumba
HMHerman Mwanja
Herman Mwanja
JMJonathan Mayito
Jonathan Mayito
BMBetty Mbolanyi
Betty Mbolanyi
FIFred Isaasi
Fred Isaasi
SESimon Etimu
Simon Etimu
Background: Antimicrobial irrational use and poor disposal in the human and animal sectors promote antimicrobial resistance (AMR) in the environment as these antimicrobials and their active ingredients, coupled with resistant microbes, are released into the environment. While AMR containment programs in the human and animal sectors are well established in Uganda, those in the water and environment sector still need to be established and strengthened. Therefore, the Ministry of Water and Environment set out to establish an AMR surveillance program to bolster the One Health efforts for the containment of AMR under the National Action Plan 2018-2023. Objective: This study aims to describe Uganda’s experience in establishing AMR surveillance in the water and environment sector. Methods: A methodical qualitative and quantitative description of the steps undertaken between August 2021 and March 2023 to establish an AMR surveillance system in the water and environment sector is provided. The Uganda Ministry of Water and Environment used a stepwise approach. Governance structures were streamlined, and sector-specific AMR surveillance guiding documents were developed, pretested, and rolled out. The National Water Quality Reference Laboratory infrastructure and microbiology capacity were enhanced to aid AMR detection and surveillance using conventional culture-based methods. A passive and targeted active surveillance hybrid was used to generate AMR data. Passive surveillance used remnants of water samples collected routinely for water quality monitoring while targeted active surveys were done at selected sites around the Kampala and Wakiso districts. Excel and Stata 15 statistical software were used for data analysis. Results: A sector-specific technical working group of 10 members and focal persons is in place, providing strategic direction and linkage to the national AMR surveillance program. The National Water Quality Reference Laboratory is now at biosafety level 2 and conducting microbiology testing using conventional culture-based techniques. Up to 460 water samples were processed and 602 bacterial isolates were recovered, of which 399 (66.3%) and 203 (33.7%) were priority pathogens and nonpriority pathogens, respectively. Of the 399 priority pathogens, 156 (39.1%), 140 (35.1%), 96 (24.1%), and 7 (1.8%) were Escherichia coli, Klebsiella species, Enterococcus species, and Salmonella species, respectively. E coli showed resistance to ampicillin (79%), ciprofloxacin (29%), and ceftriaxone (29%). Similarly, Klebsiella species showed resistance to ampicillin (100%), ciprofloxacin (17%), and ceftriaxone (18%). Enterococcus species showed resistance to ciprofloxacin (52%), vancomycin (45%), and erythromycin (56%). Up to 254 (63.7%) of the priority pathogens recovered exhibited multiple and extensive resistance to the different antibiotics set. Conclusions: Initial efforts to establish and implement AMR surveillance in the water and environment sector have succeeded in streamlining governance and laboratory systems to generate AMR data using conventional culture-based methods.

14 April 2025 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
RMRodney Mugasha
Rodney Mugasha
AKAndrew Kwiringira
Andrew Kwiringira
VNVivian Ntono
Vivian Ntono
LNLydia Nakiire
Lydia Nakiire
IAImmaculate Ayebazibwe
Immaculate Ayebazibwe
MLMohammed Lamorde
Mohammed Lamorde
In 2017, Uganda implemented an electronic Integrated Disease Surveillance and Response System (eIDSR) to improve data completeness and reporting timelines. However, the eIDSR system had limited functionality and was implemented on a small scale. The Ministry of Health, with support from the Infectious Disease Institute, Makerere University, and Health Information Systems Program Uganda, upgraded the system functionality and scaled up its implementation. This study describes the process and impact of upgrading eIDSR functionality and expanding its implementation across additional districts. The Ministry of Health, through its Integrated Epidemiology, Surveillance & Public Health Emergency Department, coordinated the implementation of the eIDSR. User requirements were identified through consultations with national surveillance stakeholders. The feedback informed the design and development of the upgraded eIDSR functionalities. The eIDSR rollout followed a consultative workshop to create awareness of the system among stakeholders. A curriculum was developed, and a national training of trainers was conducted. These trainers cascaded the training to the district health teams, who later cascaded the training to health workers. The training adopted an on-site training approach, where a group of national or district trainers would train new users at their desks. The eIDSR system was upgraded to the District Health Information Software 2 (DHIS2) 2.35 platform featuring faster reading and writing tracker data, handling over 100 concurrent users and enhanced case-based surveillance features on Android and web platforms. From October 2020 to September 2022, the eIDSR was rolled out in 68% (100/146) of districts. Additionally, the system permitted prompt reporting of signals of epidemic-prone diseases. Improving the functionality and the expanded geographical scope of the eIDSR system enhanced disease surveillance. Stakeholder commitment and leveraging existing structures will be needed to scale up eIDSR.

1 July 2025 in BMJ Public Health
Verified
Journal Article
Open access
PDF file
IMIsrael Mugezi
Israel Mugezi
VTVivian Twemanye
Vivian Twemanye
EIEmmanuel Isingoma
Emmanuel Isingoma
CNCeaser Adibaku Nyolimati
Ceaser Adibaku Nyolimati
JMJonathan Mayito
Jonathan Mayito
AMAdrian Muwonge
Adrian Muwonge
Introduction: Rising poultry demand is driving shifts towards intensive farming in the Global South, raising concerns about antibiotic use and food chain risks. This study examines the nature and extent of antibiotic use in Uganda’s commercial poultry sector and quantifies antibiotic use at bird, farm and national levels. Further, the study estimates antibiotic residues in broiler, layer and duo-purpose poultry meat at slaughter to evaluate food chain risks. Methods: This cross-sectional survey used the World Organisation for Animal Health standards for monitoring quantities of antimicrobial agents used in food-producing animals, on 374 commercial poultry farms with 187 798 birds randomly selected from the Northern, West Nile, Eastern and Southwestern subregions of Uganda. Results: The overall antibiotic use was 82 kg per farm per cycle, with variability by poultry type, farm size and at regional level, that is, ~170 mg more were used in broiler than dual-purpose birds, ~220 mg more were used on broiler than layer farms, ~180 g more used in the Southwestern than the Eastern region. Smaller farms (≤200 birds) use 1050 mg more than larger farms (≥800 birds). Drug formulation (whether powdered or liquid) and access to veterinary extension services were associated with higher and lower antibiotic use, respectively. 24.7 tons (~63% of the poultry annual antibiotic imports) are used by the commercial sector. Tetracycline and colistin sulphate are the most used, and we estimated 14% and 54% of broiler farms with non-adherence to their withdrawal periods, respectively, exceeding maximum residue levels of 150 ng/kg and 200 ng/kg of meat. Conclusions: We estimate that the commercial poultry sector, that makes 30% of the national poultry population, uses 63% of imported antibiotics, with potential public health implications such as residues in the food chain. Interventions should be tailored to poultry production types hinged on robust veterinary extension services.

1 October 2020 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
MKMaureen Kesande
Maureen Kesande
MLMohammed Lamorde
Mohammed Lamorde
EBElizabeth Bancroft
Elizabeth Bancroft
CHCarolyn Herzig
Carolyn Herzig
JNJudith Nanyondo
Judith Nanyondo
JBJustine Bukirwa
Justine Bukirwa
Background: In June 2019, 3 people were diagnosed with Ebola virus disease (EVD) in Kasese district, Uganda, all of whom had come from the Democratic Republic of Congo (DRC). Although no secondary transmission of Ebola occurred, an assessment of infection prevention and control (IPC) using the WHO basic IPC facility assessment checklist revealed significant gaps. Robust IPC systems are critical for the prevention of healthcare-associated infections like EVD. A rapid intervention was developed and implemented in Kasese to strengthen IPC capacity in high-risk facilities. Methods: Of 117 healthcare facilities, 50 were considered at high risk of receiving suspected EVD cases from DRC based on population movement assessments. In August 2019, IPC mentors were selected from 25 high-risk facilities and assigned to support their facility and a second high-risk facility. Mentors ensured formation of IPC committees and implemented the national mentorship strategy for IPC preparedness in non-EVD treatment facilities. This effort focused on screening, isolation, and notification of suspect cases: 4 mentorship visits were conducted (1 per week for 1 month). Middle and terminal assessments were conducted using the WHO IPC checklist 2 and 4 weeks after the intervention commenced. Results were evaluated against baseline data. Results: Overall, 39 facilities had data from baseline, middle, and end assessments. Median scores in facility IPC standard precautions increased from baseline 50% (IQR, 39%–62%) to 73% (IQR, 67%–76%) at the terminal assessments. Scores increased for all measured parameters except for water source (access to running water). Greatest improvements were seen in formation of IPC committees (41% to 75%), hand hygiene compliance (47% to 86%), waste management (51% to 83%), and availability of dedicated isolation areas (16% to 42%) for suspect cases. Limited improvement was noted for training on management of suspect isolated cases and availability of personal protective equipment (PPE) (Fig. 1). No differences were noted in scores for facilities with nonresident mentors versus those with resident mentors at baseline (48% vs 50%) and end assessments (72% vs 74%). Conclusions: This intervention improved IPC capacity in health facilities while avoiding the cost and service disruption associated with large-scale classroom-based training of health workers. The greatest improvements were seen in activities relying on behavior change, such as hand hygiene, IPC committee, and waste management. Smaller changes were seen in areas requiring significant investments such as isolation areas, steady water source, and availability of personal protective equipment (PPE). Mentorship is ongoing in moderate- and lower-risk facilities in Kasese district. Funding: None Disclosures: Mohammed Lamorde reports contract research for Janssen Pharmaceutica, ViiV, Mylan.